Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Solana CoHSDT · Entity 6630 | Chief Medical Officer | October 05, 2020 | October 07, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Solana Co
Report date October 05, 2020 · Filed October 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.40 · Expires 2030-10-05 | Direct | 60,000 |
Reported balance
After 2020-10-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-10-05 · Grant · Acquired 60,000 · Balance 60,000 F1: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of two (2) successive equal annual installments measured from October 5, 2020, subject to the Reporting Person's continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of two (2) successive equal annual installments measured from October 5, 2020, subject to the Reporting Person's continued service through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2020 Filed Oct 7, 2020 20:17 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001209191-20-054127 · doc4.xml · derivative · entry 1 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2030-10-05 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of two (2) successive equal annual installments measured from October 5, 2020, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 21:45 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.32 | $0.00 |
DisclosureSEC source: 0001209191-20-025152 · doc4.xml · derivative · entry 1 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2030-04-15 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of four (4) successive equal annual installments measured from April 16, 2020, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 13:37 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001209191-20-020579 · doc4.xml · derivative · entry 1 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2030-03-18 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of four (4) successive equal annual installments measured from March 19, 2020, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| December 07, 2019 Filed Dec 17, 2019 00:53 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001209191-19-060770 · doc4.xml · derivative · entry 4 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Class A Common Stock · 120,000 shares Expires 2026-07-13 F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date. F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| December 07, 2019 Filed Dec 17, 2019 00:53 UTC | Solana Co HSDT · Entity 6630 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001209191-19-060770 · doc4.xml · derivative · entry 3 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 120,000 shares Expires 2020-07-13 F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date. F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| December 07, 2019 Filed Dec 17, 2019 00:53 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $12.72 | $0.00 |
DisclosureSEC source: 0001209191-19-060770 · doc4.xml · derivative · entry 2 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A Common Stock · 80,000 shares Expires 2024-12-08 F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 8, 2014 resulting in the deemed cancellation of the December 8, 2014 option and the grant of a replacement option with the same terms other than the expiration date. F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| December 07, 2019 Filed Dec 17, 2019 00:53 UTC | Solana Co HSDT · Entity 6630 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $12.72 | $0.00 |
DisclosureSEC source: 0001209191-19-060770 · doc4.xml · derivative · entry 1 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 80,000 shares Expires 2019-12-08 F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 8, 2014 resulting in the deemed cancellation of the December 8, 2014 option and the grant of a replacement option with the same terms other than the expiration date. F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| March 28, 2019 Filed Apr 2, 2019 01:15 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $6.76 | $0.00 |
DisclosureSEC source: 0001209191-19-022119 · doc4.xml · derivative · entry 1 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of forty-eight (48) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| May 15, 2018 Filed May 18, 2018 00:20 UTC | Solana Co HSDT · Entity 6630 | GrantEmployee Stock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $10.99 | $0.00 |
DisclosureSEC source: 0001209191-18-031236 · doc4.xml · derivative · entry 2 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A Common Stock · 80,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15. F4 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest in a series of forty-eight (48) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 15, 2018 Filed May 18, 2018 00:20 UTC | Solana Co HSDT · Entity 6630 | OtherClass A Common Stock | 62,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031236 · doc4.xml · nonDerivative · entry 1 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,403 F1 · kind: Pro rata distribution from Clinvue LLC, of which the Reporting Person was a member. F2 · balance_after: The amount reported reflects a pro rata distribution to members of MPJ Healthcare. In prior reports, the Reporting Person reported beneficial ownership of 641,401 shares, on a post-split basis. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 22:57 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 326,624 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000899243-17-010583 · doc4.xml · derivative · entry 2 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,624 Underlying: Class A Common Stock · 326,624 shares Expires 2027-04-17 F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16 F3 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 22:57 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 473,376 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000899243-17-010583 · doc4.xml · derivative · entry 1 Sackier Jonathan · CIK 0001638293 · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,376 Underlying: Class A Common Stock · 473,376 shares Expires 2027-04-17 F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16 F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.